Both in Electromedical Equipment
CapsoVision vs Neuraxis
Over the past year CV returned +40.2% and NRXS returned +145.5%; their daily moves had a correlation of 0.05.
CV +40.2% NRXS +145.5%Growth of $1, one year, split-adjusted
| Metric | CV | NRXS |
|---|---|---|
| Price | $6.70 | $6.58 |
| Market cap | $356.5M | $82.6M |
| Today | −0.45% | −0.30% |
| 1 month | +1.7% | −8.0% |
| 6 months | −5.1% | −24.3% |
| Year to date | −37.3% | +44.9% |
| 1 year | +37.3% | +141.9% |
| Revenue growth (YoY) | — | +115.7% |
| Gross margin | 51.4% | 85.9% |
| Net margin | −205.4% | −118.1% |
| P/E (TTM) | — | — |
| Price / sales | 25.7× | 15.5× |
| Net cash | $9.1M | $8.3M |
| Dividend yield | — | — |
| Volatility (60d) | 49.2% | 71.7% |
| Short % of float | 6.4% | 4.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).